Rotavirus vaccines--balancing intussusception risks and health benefits

doi:10.1056/NEJMe1315836

Editorial

. 2014 Feb 6;370(6):568-70.

doi: 10.1056/NEJMe1315836. Epub 2014 Jan 14.

Rotavirus vaccines--balancing intussusception risks and health benefits

Roger I Glass¹, Umesh D Parashar

Affiliations

Affiliation

¹ From the Fogarty International Center, National Institutes of Health, Bethesda, MD (R.I.G.); and the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta (U.D.P.).

PMID: 24422677
PMCID: PMC5716463
DOI: 10.1056/NEJMe1315836

Editorial

Rotavirus vaccines--balancing intussusception risks and health benefits

Roger I Glass et al. N Engl J Med. 2014.

. 2014 Feb 6;370(6):568-70.

doi: 10.1056/NEJMe1315836. Epub 2014 Jan 14.

Authors

Roger I Glass¹, Umesh D Parashar

Affiliation

¹ From the Fogarty International Center, National Institutes of Health, Bethesda, MD (R.I.G.); and the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta (U.D.P.).

PMID: 24422677
PMCID: PMC5716463
DOI: 10.1056/NEJMe1315836

No abstract available

PubMed Disclaimer

Comment on

Intussusception risk after rotavirus vaccination in U.S. infants.
Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Yih WK, et al. N Engl J Med. 2014 Feb 6;370(6):503-12. doi: 10.1056/NEJMoa1303164. Epub 2014 Jan 14. N Engl J Med. 2014. PMID: 24422676
Risk of intussusception after monovalent rotavirus vaccination.
Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, DeStefano F. Weintraub ES, et al. N Engl J Med. 2014 Feb 6;370(6):513-9. doi: 10.1056/NEJMoa1311738. Epub 2014 Jan 14. N Engl J Med. 2014. PMID: 24422678

Cited by

A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.
Xia M, Huang P, Tan M. Xia M, et al. Pharmaceutics. 2022 Jul 30;14(8):1597. doi: 10.3390/pharmaceutics14081597. Pharmaceutics. 2022. PMID: 36015223 Free PMC article.
Rotavirus Vaccination Likely to Be Cost Saving to Society in the United States.
Newall AT, Leong RN, Reyes JF, Curns AT, Rudd J, Tate J, Macartney K, Parashar U. Newall AT, et al. Clin Infect Dis. 2021 Oct 20;73(8):1424-1430. doi: 10.1093/cid/ciab442. Clin Infect Dis. 2021. PMID: 34038527 Free PMC article.
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
Xia M, Huang P, Jiang X, Tan M. Xia M, et al. Viruses. 2021 Jan 6;13(1):72. doi: 10.3390/v13010072. Viruses. 2021. PMID: 33419150 Free PMC article.
Effects of rotavirus NSP4 protein on the immune response and protection of the S_R69A-VP8* nanoparticle rotavirus vaccine.
Liu C, Huang P, Zhao D, Xia M, Zhong W, Jiang X, Tan M. Liu C, et al. Vaccine. 2021 Jan 8;39(2):263-271. doi: 10.1016/j.vaccine.2020.12.005. Epub 2020 Dec 11. Vaccine. 2021. PMID: 33309483 Free PMC article.
Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
Xia M, Huang P, Jiang X, Tan M. Xia M, et al. Vaccine. 2019 Jul 9;37(30):4103-4110. doi: 10.1016/j.vaccine.2019.05.075. Epub 2019 Jun 11. Vaccine. 2019. PMID: 31201052 Free PMC article.

See all "Cited by" articles

References

1. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. - PubMed
1. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. - PubMed
1. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72. - PubMed
1. Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009–2011. Clin Infect Dis. 2013;57:13–20. - PMC - PubMed
1. Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J. 2011;30(Suppl):S30–S34. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

CC999999/Intramural CDC HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

[1] Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. - PubMed

[2] Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. - PubMed

[3] Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. - PubMed

[4] Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. - PubMed

[5] Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72. - PubMed

[6] Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72. - PubMed

[7] Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009–2011. Clin Infect Dis. 2013;57:13–20. - PMC - PubMed

[8] Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009–2011. Clin Infect Dis. 2013;57:13–20. - PMC - PubMed

[9] Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J. 2011;30(Suppl):S30–S34. - PubMed

[10] Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J. 2011;30(Suppl):S30–S34. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Rotavirus vaccines--balancing intussusception risks and health benefits

Affiliation

Rotavirus vaccines--balancing intussusception risks and health benefits

Authors

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources